Screening and counselling in the primary care setting for women who have experienced intimate partner violence (WEAVE): a cluster randomised controlled trial

Integrating Intimate Partner Violence Assessment and Intervention into Healthcare in the United States: A Systems Approach

“…[11][12][13][14][15][16][17][18][19] Possible harms or unintended consequences of clinical assessment have been raised and considered in research trials, but thus far no evidence of such harm has emerged. [19][20][21] Barriers for implementation of IPV screening and counseling are myriad, including clinician concerns about time; limited incentives for screening 22 ; either nonexistent or poorly implemented policies to guide clinicians and practices in conducting screening; lack of knowledge and confidence about how to support a patient who discloses IPV, [23][24][25][26][27] which may reflect lack of reliable intervention services 28 ; and inadequate crosssector collaborations with victim service advocates. 29,30 Addressing barriers and improving screening, counseling, and referral practices require attention to multiple levels within the healthcare delivery system to create a safe, trusting environment for patients.…”

Women’s experiences of referral to a domestic violence advocate in UK primary care settings: a service-user collaborative study

“…2 However, there is still uncertainty about effective responses from clinicians, 3 including those working in general practice, 4 and about how women experience programmes such as IRIS that are designed to improve clinician engagement with DVA.…”

“…1 A meta-analysis of qualitative studies found women survivors of DVA see healthcare professionals as potential sources of support. 2 However, there is still uncertainty about effective responses from clinicians, 3 including those working in general practice, 4 and about how women experience programmes such as IRIS that are designed to improve clinician engagement with DVA.…”

“…The programme trains clinicians in identification, initial response or validation, referral to specialist DVA advocacy, and continuing support.In a cluster randomised trial the IRIS intervention had a substantial effect on identification of women experiencing DVA and on referral to DVA advocacy.1 A meta-analysis of qualitative studies found women survivors of DVA see healthcare professionals as potential sources of support.2 However, there is still uncertainty about effective responses from clinicians, 3 including those working in general practice, 4 and about how women experience programmes such as IRIS that are designed to improve clinician engagement with DVA.The aims of this study were to understand women's experiences of disclosure of DVA in general practice settings in the context of the IRIS programme, focusing on women's subsequent referral by their GP or practice nurse to a DVA advocate. The study set out to explore women's experience of the initial contact with an advocate after the GP referral and their views on how important this initial meeting and contact was to any changes that they subsequently reported in attitude and behaviour that improved their sense of safety.…”

Cochrane in CORR ®: Screening Women for Intimate Partner Violence in Healthcare Settings (Review)

“…In fact, these findings highlight the fact that screening alone does not necessarily lead to improvements in any meaningful outcomes for patients, and perhaps a more rigorous ''active'' intervention is warranted. Trials evaluating IPV identification paired with referral or counselling services, which were not included in this review, demonstrate a positive impact on the lives of patients who have experienced IPV [5,6]. We recommend that IPV interventions go beyond identification alone, and are evaluated based on patient-important outcomes such as reduction in IPV frequency and/or severity, or IPV-related health outcomes that directly impact a patient's health and well-being.…”